Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07151339

Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia

Tertiary prevention program for women with preeclampsia, HELLP syndrome, kidney disease and pregnancy or associated conditions, including founding of a biobank. (Observational study since no interference with regular path of treatment suggested in national and international guidelines)

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • older than 18 yrs
  • diagnosed preeclampsia, HELLP syndrome or kidney disease durig pregnancy

Exclusion criteria

  • unable for informed consent

Treatment and study plan

Primary outcomes

  1. Pulse wave velocity

    Time frame: 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Laura K Sievers, MD

CONTACT

[email protected]

+49 431 500 23001

Sponsors and collaborators

Lead sponsor

University Hospital Schleswig-Holstein

Other

Registry information

Official study title

Pilotprojekt Renale Und kardiovaskuläre Tertiärprävention Nach Präeklampsie

Acronym: EagleEye3P

Important dates

Study start
2024
Primary completion
2029
Study completion
2030
First posted
Sep 3, 2025
Registry last updated
Sep 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.